Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Cancers
|
May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study
Fabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series
Kuven K Moodley, Daniela Perani, Ludovico Minati, et al.
Clinical Nuclear Medicine
|
January 24, 2022
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort
Gabriele Ironi, Paola Mapelli, Alice Bergamini, et al.
Nuclear Medicine Communications
|
September 14, 2020
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer
Paola Mapelli, Gabriele Ironi, Alice Bergamini, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
British Journal of Haematology
|
December 21, 2010
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
Andrea Gallamini, Caterina Patti, Simonetta Viviani, et al.
Cancers
|
January 28, 2026
[<sup>18</sup>F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment
Carolina Bezzi, Gabriele Ironi, Tommaso Russo, et al.
Blood
|
May 24, 2019
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Andrés J M Ferreri, Teresa Calimeri, Gian Marco Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Blood Advances
|
August 9, 2020
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Andrés J M Ferreri, Teresa Calimeri, Maurilio Ponzoni, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Cancers
|
May 30, 2019
<sup>18</sup>F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study
Fabio Zattoni, Elena Incerti, Fabrizio Dal Moro, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series
Kuven K Moodley, Daniela Perani, Ludovico Minati, et al.
Clinical Nuclear Medicine
|
January 24, 2022
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort
Gabriele Ironi, Paola Mapelli, Alice Bergamini, et al.
Nuclear Medicine Communications
|
September 14, 2020
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer
Paola Mapelli, Gabriele Ironi, Alice Bergamini, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
British Journal of Haematology
|
December 21, 2010
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
Andrea Gallamini, Caterina Patti, Simonetta Viviani, et al.
Cancers
|
January 28, 2026
[<sup>18</sup>F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment
Carolina Bezzi, Gabriele Ironi, Tommaso Russo, et al.
Blood
|
May 24, 2019
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma
Andrés J M Ferreri, Teresa Calimeri, Gian Marco Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2020
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini, Andrea Rossi, Caterina Patti, et al.
Blood Advances
|
August 9, 2020
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
Andrés J M Ferreri, Teresa Calimeri, Maurilio Ponzoni, et al.
Page
of 6